Actively Recruiting
Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery
Led by Mayo Clinic · Updated on 2025-09-11
40
Participants Needed
1
Research Sites
253 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to determine the optimum dose of Dexmedetomidine to stop shivering in 90% of patients who experience shivering during scheduled elective cesarean deliveries.
CONDITIONS
Official Title
Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women presenting for planned cesarean delivery
- American Society of Anesthesiology Physical Classification Status 2 or 3 without major medical co-morbidities
- Singleton pregnancy between 28 and 42 weeks gestation
- Use of spinal anesthesia technique
You will not qualify if you...
- Any contraindication to spinal anesthesia technique
- Allergy or intolerance to dexmedetomidine or clonidine
- Oral temperature below 36 degrees Celsius before procedure
- Unable to give personal consent
- Preterm premature rupture of membranes (PPROM) or infection concerns such as chorioamnionitis
- Conversion to general anesthesia before randomization
- Use of sedative medications like fentanyl, midazolam, ketamine, or nitrous oxide before randomization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
H
Hans P Sviggum, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here